• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚太地区一种快速出现的疾病的流行病学:非酒精性脂肪性肝病

Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease.

作者信息

Wah-Kheong Chan, Khean-Lee Goh

机构信息

Gastroenterology and Hepatology Unit, Gastrointestinal Endoscopy Unit, Department of Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.

出版信息

Hepatol Int. 2013 Mar;7(1):65-71. doi: 10.1007/s12072-012-9384-1. Epub 2012 Jun 15.

DOI:10.1007/s12072-012-9384-1
PMID:26201622
Abstract

Non-alcoholic fatty liver disease (NAFLD) is rapidly increasing in the Asia-Pacific and affects up to 30 % of the general population. In younger children, prevalence has been reported to be between 2.1 and 4.5 %. The prevalence of NAFLD increases with increasing age. NAFLD is more prevalent in men than women, but this trend fades in older age group. NAFLD is one of the most common causes of raised serum ALT levels and the latter is closely related to the presence of features of metabolic syndrome. NAFLD may contribute to metabolic syndrome in a similar way as visceral adiposity and can be an early predictor of metabolic disorders. NAFLD increases the risk of developing diabetes mellitus and is closely related to degree of glucose intolerance. A significant proportion of patients with NAFLD have impaired glucose tolerance or diabetes mellitus but with normal fasting blood glucose, highlighting the importance of oral glucose tolerance test in NAFLD patients with normal fasting blood glucose. Besides liver-related complications, NAFLD has been associated with cardiovascular complications, hyperuricemia, gout, chronic kidney disease, gallstone disease, colorectal adenomatous polyp, and polycystic ovarian syndrome. NAFLD seems to be related to host metabolic factors rather than viral factors and does not seem to affect severity of the liver disease in patients with chronic hepatitis B. On the other hand, hepatic steatosis may be related to both host metabolic and viral factors in patients with chronic hepatitis C and seems to adversely impact on the severity of liver disease and possibly response to antiviral therapy.

摘要

非酒精性脂肪性肝病(NAFLD)在亚太地区正迅速增加,影响着高达30%的普通人群。在年幼儿童中,据报道患病率在2.1%至4.5%之间。NAFLD的患病率随年龄增长而增加。NAFLD在男性中比女性更普遍,但这种趋势在老年人群中逐渐减弱。NAFLD是血清ALT水平升高的最常见原因之一,而血清ALT水平升高与代谢综合征的特征密切相关。NAFLD可能以与内脏肥胖相似的方式导致代谢综合征,并且可能是代谢紊乱的早期预测指标。NAFLD增加了患糖尿病的风险,并且与葡萄糖不耐受程度密切相关。相当一部分NAFLD患者有糖耐量受损或糖尿病,但空腹血糖正常,这凸显了口服葡萄糖耐量试验在空腹血糖正常的NAFLD患者中的重要性。除了肝脏相关并发症外,NAFLD还与心血管并发症、高尿酸血症、痛风、慢性肾脏病、胆结石病、结直肠腺瘤性息肉和多囊卵巢综合征有关。NAFLD似乎与宿主代谢因素而非病毒因素有关,并且似乎不影响慢性乙型肝炎患者的肝病严重程度。另一方面,肝脂肪变性在慢性丙型肝炎患者中可能与宿主代谢和病毒因素都有关,并且似乎对肝病严重程度有不利影响,可能还会对抗病毒治疗反应产生影响。

相似文献

1
Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease.亚太地区一种快速出现的疾病的流行病学:非酒精性脂肪性肝病
Hepatol Int. 2013 Mar;7(1):65-71. doi: 10.1007/s12072-012-9384-1. Epub 2012 Jun 15.
2
How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?非酒精性脂肪性肝病在亚太地区的发病率如何,是否存在地区差异?
J Gastroenterol Hepatol. 2007 Jun;22(6):788-93. doi: 10.1111/j.1440-1746.2007.05042.x.
3
Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.印度南部城市非酒精性脂肪性肝病的患病率与不同程度的葡萄糖不耐受和代谢综合征的关系。
Diabetes Res Clin Pract. 2009 Apr;84(1):84-91. doi: 10.1016/j.diabres.2008.11.039. Epub 2009 Jan 24.
4
Nonalcoholic fatty liver disease in Asia: emerging perspectives.亚洲的非酒精性脂肪性肝病:新视角。
J Gastroenterol. 2017 Feb;52(2):164-174. doi: 10.1007/s00535-016-1264-3. Epub 2016 Sep 16.
5
What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?亚太地区非酒精性脂肪性肝病的风险因素及相关情况有哪些?
J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. doi: 10.1111/j.1440-1746.2007.04952.x. Epub 2007 May 13.
6
Non-alcoholic fatty liver disease and hepatitis C infection.非酒精性脂肪性肝病与丙型肝炎感染
Minerva Gastroenterol Dietol. 2006 Jun;52(2):135-43.
7
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations.丙型肝炎病毒感染中的非酒精性脂肪性肝病和非酒精性脂肪性肝炎:在肝脏和肝外表现中的患病率及意义
Int J Mol Sci. 2016 May 25;17(6):803. doi: 10.3390/ijms17060803.
8
Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.亚太地区的非酒精性脂肪性肝病:定义及拟议指南概述
J Gastroenterol Hepatol. 2007 Jun;22(6):778-87. doi: 10.1111/j.1440-1746.2007.05001.x.
9
Glycoregulation disorders and alterations of C reactive protein in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的糖调节紊乱与C反应蛋白改变
Rom J Intern Med. 2006;44(4):419-26.
10
Impact of non-alcoholic fatty liver disease on chronic hepatitis B.非酒精性脂肪性肝病对慢性乙型肝炎的影响。
Liver Int. 2007 Jun;27(5):607-11. doi: 10.1111/j.1478-3231.2007.01482.x.

引用本文的文献

1
The burden of non-alcoholic fatty liver disease among working-age people in the Western Pacific Region, 1990-2019: an age-period-cohort analysis of the Global Burden of Disease study.《1990-2019 年西太平洋地区工作年龄人群非酒精性脂肪性肝病负担:全球疾病负担研究的年龄-时期-队列分析》。
BMC Public Health. 2024 Jul 11;24(1):1852. doi: 10.1186/s12889-024-19047-y.
2
Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study.瞬时弹性成像在肥胖的非酒精性脂肪性肝病亚洲患者中是表现最佳的非侵入性肝纤维化检测方法:一项初步的、横断面研究。
Medicina (Kaunas). 2024 Jan 17;60(1):169. doi: 10.3390/medicina60010169.
3

本文引用的文献

1
Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia.马来西亚一个多民族郊区亚洲人群中非酒精性脂肪性肝病的患病率及危险因素
Hepatol Int. 2013 Jun;7(2):548-54. doi: 10.1007/s12072-012-9359-2. Epub 2012 Mar 23.
2
Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.2型糖尿病患者非酒精性脂肪性肝病的患病率及其与冠心病危险因素的相关性
J Assoc Physicians India. 2011 Jun;59:351-4.
3
Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection.
Liver Transplant Outcomes in Young Adults with Cirrhosis Related to Nonalcoholic Fatty Liver Disease.
非酒精性脂肪性肝病相关肝硬化的年轻成人肝移植结局。
Transplant Proc. 2023 Nov;55(9):2134-2142. doi: 10.1016/j.transproceed.2023.08.020. Epub 2023 Sep 24.
4
Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial.地中海饮食对非酒精性脂肪性肝病患者肝脏和代谢结局的影响:MEDINA 随机对照试验。
Liver Int. 2022 Jun;42(6):1308-1322. doi: 10.1111/liv.15264. Epub 2022 Apr 26.
5
The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.非酒精性脂肪性肝病与2型糖尿病的共存
J Clin Med. 2022 Mar 2;11(5):1375. doi: 10.3390/jcm11051375.
6
Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease.评估接受 exenatide 治疗的非酒精性脂肪性肝病糖尿病患者的肝纤维化、FIB-4 和 APRI 评分。
Sci Rep. 2022 Jan 7;12(1):283. doi: 10.1038/s41598-021-04361-x.
7
Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia.南亚农村社区非肥胖和肥胖非酒精性脂肪性肝病的患病率、危险因素和代谢特征。
BMJ Open Gastroenterol. 2020 Dec;7(1). doi: 10.1136/bmjgast-2020-000535.
8
Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial.中药苓桂术甘汤治疗脾阳虚型非酒精性脂肪性肝病的多中心随机对照研究方案
Trials. 2020 Jun 10;21(1):512. doi: 10.1186/s13063-020-04362-7.
9
Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease.经活检证实的非酒精性脂肪性肝病在胆结石病患者中的患病率。
Saudi J Gastroenterol. 2020 Apr 14;26(4):204-9. doi: 10.4103/sjg.SJG_29_20.
10
Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.移动技术辅助生活方式干预对非酒精性脂肪性肝病患者体重减轻的影响:随机对照试验。
JMIR Mhealth Uhealth. 2020 Apr 13;8(4):e14802. doi: 10.2196/14802.
埃及慢性丙型肝炎病毒感染患者的胰岛素抵抗、脂肪变性和纤维化。
Saudi J Gastroenterol. 2011 Jul-Aug;17(4):245-51. doi: 10.4103/1319-3767.82578.
4
Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.非酒精性脂肪性肝病的流行情况及其对中国代谢综合征患者丙氨酸氨基转移酶的影响。
J Gastroenterol Hepatol. 2011 Apr;26(4):722-30. doi: 10.1111/j.1440-1746.2010.06509.x.
5
Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.性别相关的脂肪分布差异和脂肪细胞因子影响青少年非酒精性脂肪性肝病。
Hepatology. 2011 Mar;53(3):800-9. doi: 10.1002/hep.24097.
6
Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者左心室收缩和舒张功能障碍。
Cardiol J. 2010;17(5):457-63.
7
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease.非酒精性脂肪性肝炎与慢性肾脏病风险增加。
Metabolism. 2011 May;60(5):735-9. doi: 10.1016/j.metabol.2010.07.022. Epub 2010 Sep 3.
8
Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women.n-3 多不饱和脂肪酸摄入与非酒精性脂肪性肝病:日本男女的横断面研究。
Eur J Clin Nutr. 2010 Oct;64(10):1179-85. doi: 10.1038/ejcn.2010.139. Epub 2010 Aug 4.
9
Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects.非酒精性脂肪性肝病对非糖尿病患者 HbA1c 水平相关胰岛素抵抗的影响。
Am J Gastroenterol. 2010 Nov;105(11):2389-95. doi: 10.1038/ajg.2010.275. Epub 2010 Jul 13.
10
Gout and risk of non-alcoholic fatty liver disease.痛风与非酒精性脂肪性肝病风险。
Scand J Rheumatol. 2010 Nov;39(6):466-71. doi: 10.3109/03009741003742797. Epub 2010 Jun 21.